Study S000975

A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Phase ⅡStudy to Evaluate the Efficacy and Safety of HRS-7535 in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

ClinicalTrials.gov record

Registration

Registration: NCT06393348
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 155
Start: 2024-05-17
Primary completion: 2024-11-15
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:HRS-7535; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change in HbA1c from baseline at Week 16 [Week 16]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.